The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(S)-2-{(2S,3S)-2-[(S)-2-{[3-(6-Guanidino-hexyl)-7-(5-guanidino-pentyloxy)-1H-indole-2-carbonyl]-amino}-3-(4-hydroxy-phenyl)-propionylamino]-3-methyl-pentanoylamino}-4-methyl-pentanoic acid with di TFA ID: ALA21448
PubChem CID: 44274347
Max Phase: Preclinical
Molecular Formula: C45H67F3N10O9
Molecular Weight: 835.06
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)c1[nH]c2c(OCCCCCN=C(N)N)cccc2c1CCCCCCN=C(N)N)C(=O)N[C@@H](CC(C)C)C(=O)O.O=C(O)C(F)(F)F
Standard InChI: InChI=1S/C43H66N10O7.C2HF3O2/c1-5-27(4)35(39(56)51-33(41(58)59)24-26(2)3)53-38(55)32(25-28-17-19-29(54)20-18-28)50-40(57)37-31(14-9-6-7-10-21-48-42(44)45)30-15-13-16-34(36(30)52-37)60-23-12-8-11-22-49-43(46)47;3-2(4,5)1(6)7/h13,15-20,26-27,32-33,35,52,54H,5-12,14,21-25H2,1-4H3,(H,50,57)(H,51,56)(H,53,55)(H,58,59)(H4,44,45,48)(H4,46,47,49);(H,6,7)/t27-,32-,33-,35-;/m0./s1
Standard InChI Key: UBEOEKAXELGWOF-UXMXCWPGSA-N
Molfile:
RDKit 2D
67 68 0 0 0 0 0 0 0 0999 V2000
-3.7458 -7.5792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.0333 -7.1750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.0333 -6.3417 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-4.4708 -8.0000 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
-3.3333 -8.3042 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
-4.1625 -6.8625 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
-2.3208 -7.5875 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-0.9958 -1.0125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.4875 -1.6875 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.4875 -0.3417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.1708 -1.0125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.2750 -1.4292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.2750 -0.6000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5417 -3.1542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.3042 -2.4417 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.4792 -2.4417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.2417 -1.7292 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.9542 -3.8667 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.7167 -3.1542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0667 -1.7292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-7.8542 -1.4542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.7625 3.4833 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7792 -3.8667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1917 -4.5792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-8.4042 -0.8292 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.3125 2.8708 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.2417 -0.3000 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-2.9958 -1.8417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9542 -2.4417 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.0667 -3.1542 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.4792 -1.0125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7792 -5.3000 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.1917 -3.1542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.9542 3.3125 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-7.0542 -1.2917 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.0167 4.2667 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-8.1250 -2.2375 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.3042 -3.8667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.2750 -0.7917 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0167 -4.5792 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-1.2333 0.4458 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8625 -0.3542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.9958 -0.1875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8542 -1.3750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4792 0.0000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.9958 -2.6667 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.2667 0.2208 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6542 -1.1542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6542 -0.1375 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-3.7083 -0.6000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0167 -3.1542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.7083 -1.4292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.5042 -1.9125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7000 2.5333 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4792 -3.8667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.7167 -4.5792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.8000 -2.8292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.4250 0.6208 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.8917 2.3583 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.7083 -1.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.3458 -2.2042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4292 -3.8667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4292 -2.4417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.6375 1.5708 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.1583 -2.3667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.1708 1.4000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0667 -4.5792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 2 2 0
4 1 1 0
5 1 1 0
6 1 1 0
7 2 1 0
9 8 1 0
10 8 2 0
11 8 1 0
12 9 1 0
13 10 1 0
14 19 1 0
15 16 1 0
16 20 1 0
17 11 1 0
18 14 1 0
19 15 1 6
20 17 1 1
21 35 2 0
22 34 2 0
23 18 1 1
24 23 1 0
25 21 1 0
26 22 1 0
27 11 2 0
28 12 2 0
29 14 2 0
30 16 2 0
20 31 1 0
32 24 2 0
23 33 1 0
34 54 1 0
35 53 1 0
36 22 1 0
37 21 1 0
19 38 1 0
39 31 1 0
40 24 1 0
41 10 1 0
42 48 2 0
43 13 2 0
44 39 2 0
45 39 1 0
46 28 1 0
47 45 2 0
48 44 1 0
49 42 1 0
50 43 1 0
51 33 1 0
52 28 1 0
53 60 1 0
54 59 1 0
55 38 1 0
38 56 1 1
57 46 1 0
58 41 1 0
59 64 1 0
60 65 1 0
61 57 1 0
62 51 1 0
63 51 1 0
64 66 1 0
65 61 1 0
66 58 1 0
67 55 1 0
12 13 1 0
52 50 2 0
47 42 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 835.06Molecular Weight (Monoisotopic): 834.5116AlogP: 3.56#Rotatable Bonds: 27Polar Surface Area: 298.65Molecular Species: ZWITTERIONHBA: 8HBD: 10#RO5 Violations: 2HBA (Lipinski): 17HBD (Lipinski): 14#RO5 Violations (Lipinski): 3CX Acidic pKa: 4.11CX Basic pKa: 11.79CX LogP: 0.89CX LogD: 0.41Aromatic Rings: 3Heavy Atoms: 60QED Weighted: 0.03Np Likeness Score: 0.23
References 1. Dood DS, Kozikowski AP, Cusack B, Richelson E. (1994) Synthesis of partially non-peptidic neurotensin mimetics, 4 (10): [10.1016/S0960-894X(01)80338-3 ] 2. Chalon, P P and 8 more authors. 1996-05-20 Molecular cloning of a levocabastine-sensitive neurotensin binding site. [PMID:8647296 ] 3. Hughes, Francis M and 10 more authors. 2010-06-24 Identification and functional characterization of a stable, centrally active derivative of the neurotensin (8-13) fragment as a potential first-in-class analgesic. [PMID:20481538 ] 4. Fanelli, Roberto R and 9 more authors. 2017-04-27 Use of Molecular Modeling to Design Selective NTS2 Neurotensin Analogues. [PMID:28368584 ] 5. Keller, Max and 10 more authors. 2020-01-09 Fluorescence Labeling of Neurotensin(8-13) via Arginine Residues Gives Molecular Tools with High Receptor Affinity. [PMID:31938457 ] 6. Chartier, Magali and 6 more authors. 2021-02-25 Design, Structural Optimization, and Characterization of the First Selective Macrocyclic Neurotensin Receptor Type 2 Non-opioid Analgesic. [PMID:33538583 ]